Clover Health Investments board member Dr. Carladenise Armbrister Edwards sold 67,160 shares in an open-market transaction on May 18, 2026, according to an SEC filing. The sale, valued at approximately $230,000 based on a weighted average price of $3.42 per share, reduced her direct holdings by 19.05% to 285,432 shares. This marks her second direct sale in two years, following a larger 200,000-share sale in March 2025. The transaction occurred amid a one-year total return of 8.23% for the stock, which has since surged to a 52-week high of $5.49 in late June after a favorable court ruling on Medicare ratings. Edwards has not sold additional shares despite the rally, and her remaining stake suggests continued confidence in the company, which reported a 62% year-over-year revenue increase to $749.2 million in the first quarter and swung to a net profit of $27.3 million.
Clover Health Investments CorpInsider sale by board member, but small relative to holdings and company fundamentals strong; no clear directional signal.